Spinogenix

Los Angeles, CA · Founded 2016 · Privately Held (backing)

Operator of a biopharmaceutical company intended to restore the brain connections and functions lost in brain injury and neurodegenerative diseases. Spinogenix is based in Los Angeles, CA and was founded in 2016. It was valued at $335 million at its later-stage round in Mar 2026, the last priced event on record. It has raised $27.4 million across 7 recorded rounds; the latest was a $10.6 million early-stage round in Nov 2025.

PMV mark · valuation
$335.0M
Oct 2026
Priced at
its later-stage round
Mar 2026
Total raised
$27.4M
Last round
Early Stage VC
Nov 2025
What is Spinogenix worth?
$335.0MPrivateMarketView mark · Oct 2026

Valued at $335.0M at its later-stage round, Mar 2026. Nothing has traded since.

Free account
More of Spinogenix with a free account
  • ·Watch Spinogenix: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Spinogenix funding history

7 rounds
DateRoundRaisedPost-money
Nov 2025Early Stage VC$10.6M▮
Jun 2024Seed Round$2.8M▮
Jul 2023Early Stage VC$5.2M▮
Sep 2022Seed Round$3.3M▮
Feb 2021Seed Round$1.6M▮
Aug 2019Seed Round$250K▮
+ 1 earlier rounds · a free account shows the full history
Unlock post-money valuations

Membership and data by Private Market View

Spinogenix valuation

Spinogenix was valued at $335 million at its later-stage round in Mar 2026. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Spinogenix raised?

Spinogenix has raised $27.4 million across 7 recorded rounds since 2017. The largest was a $903,335 seed round in Sep 2017; the most recent was a $10.6 million early-stage round in Nov 2025.

Spinogenix has filed 8 Form Ds with the SEC since 2017, most recently in Jun 2024 ($2.8 million sold to 3 investors).

How Spinogenix's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Spinogenix, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Spinogenix

What is Spinogenix worth?
Spinogenix is valued at $335.0M as of Oct 2026. Valued at $335.0M at its later-stage round, Mar 2026. Nothing has traded since.
How much has Spinogenix raised?
Spinogenix has raised $27.4M in total funding across 7 recorded rounds.
When did Spinogenix last raise?
Spinogenix last raised in Nov 2025 (Early Stage VC), raising $10.6M.